Lv41
770 积分 2024-11-24 加入
Clinical Manifestations and Risk Factors of Liver Injury Induced by PD-1 Inhibitors in Patients with Malignancies: A Case-Control Study
1个月前
已完结
Hepatotoxicity of Chemotherapy and Immune Checkpoint Inhibitors
1个月前
已关闭
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
1个月前
已完结
The effect of pharmacist-initiated perioperative multidisciplinary pharmaceutical care model and clinical pathway on pain management in patients undergoing orthopedic surgery: a before-after study
2个月前
已完结
Obinutuzumab for treatment of membranous nephropathy in patients positive and negative for the phospholipase A2 receptor antibody: case reports
2个月前
已完结
Antimicrobial mechanism study of NIR-activated chitosan-montmorillonite hydrogel and their anti-MDR S. aureus properties in vitro pigskin model
3个月前
已完结
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
5个月前
已完结
Successful Alectinib Treatment Administered by Mixing With a Soft Diet in a Patient With Non–Small-Cell Lung Cancer With Severe Dysphagia
5个月前
已完结
Immune Checkpoint Inhibitor-Induced Psoriasis
6个月前
已完结
Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
6个月前
已完结
皖公网安备34019202002308
